GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Corteva CTVA · USD

Materials · Chemicals · US listing · 🇺🇸 United States

Compare

12.11

+1.76%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Corteva annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 31 Dec 2025, filed on 12 Feb 2026.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$17.40bn$16.91bn$17.23bn$17.45bn$15.65bn
Operating income$2.62bn$2.10bn$941.0m$1.93bn$1.35bn
Net income$1.09bn$907.0m$735.0m$1.15bn$1.76bn
Free cash flow$2.81bn$1.55bn$1.17bn$267.0m$2.15bn
Total assets$42.84bn$40.83bn$43.00bn$42.62bn$42.34bn
Shareholders' equity$24.14bn$23.79bn$25.04bn$25.30bn$25.38bn

Revenue by business

Year to 31 Dec 2025

  • Corn [Member] $7.00bn · 40.2%
  • Herbicides [Member] $3.73bn · 21.4%
  • Soybean [Member] $1.88bn · 10.8%
  • Insecticides [Member] $1.67bn · 9.6%
  • Fungicides [Member] $1.14bn · 6.6%
  • Other oilseeds [Member] $644.0m · 3.7%
  • Biologicals $519.0m · 3.0%
  • Other [Member] $445.0m · 2.6%

Revenue by region

Year to 31 Dec 2025

  • UNITED STATES $8.27bn · 47.5%
  • Latin America $3.93bn · 22.6%
  • EMEA $3.11bn · 17.9%
  • BRAZIL $2.90bn · 16.7%
  • North America [Member] $2.75bn · 15.8%
  • Asia Pacific $1.34bn · 7.7%
  • CANADA $755.0m · 4.3%

From the 2025 annual report

As filed, for the year to . A later report may be linked above: this is the newest our data supplier has processed.

As filed
Auditor
PricewaterhouseCoopers LLP
Auditor location
Philadelphia, Pennsylvania
Income statement USD ($) $ in Millions
Dec. 31, 2025Dec. 31, 2024Dec. 31, 2023
Net Sales—17,40116,90817,226
Cost of Goods Sold—9,1729,5299,920
Research and Development Expense—1,4741,4021,337
Selling, General and Administrative Expense—3,4923,1963,176
Amortization of Intangibles—644685683
Restructuring and asset related charges - net[1]146288336
Business Separation Costs—3500
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]—Other income (expense) - netOther income (expense) - netOther income (expense) - net
Other income (expense) - net—-570-300-448
Interest Expense—180233233
Income (loss) from continuing operations before income taxes—1,6881,2751,093
Provision for (benefit from) income taxes on continuing operations—484412152
Income (loss) from continuing operations after income taxes—1,204863941
Income (loss) from discontinued operations after income taxes—-9956-194
Net income (loss)—1,105919747
Net income (loss) attributable to noncontrolling interests—111212
Net Income (Loss) attributable to Company—1,094907735
Basic earnings (loss) per share of common stock from continuing operations—1.751.231.31
Basic earnings (loss) per share of common stock from discontinued operations—-0.150.08-0.27
Basic earnings (loss) per share of common stock—1.61.311.04
Diluted earnings (loss) per share of common stock from continuing operations—1.751.221.3
Diluted earnings (loss) per share of common stock from discontinued operations—-0.150.08-0.27
Diluted earnings (loss) per share of common stock—1.61.31.03
Net Sales—17,40116,90817,226
Cost of Goods Sold—9,1729,5299,920
Research and Development Expense—1,4741,4021,337
Selling, General and Administrative Expense—3,4923,1963,176
Amortization of Intangibles—644685683
Restructuring and asset related charges - net—146288336
Business Separation Costs—3500
Other income (expense) - net—-570-261-448
Interest Expense—180233253
Income (loss) from continuing operations before income taxes—1,6881,3141,073
Provision for (benefit from) income taxes on continuing operations—484421147
Income (loss) from continuing operations after income taxes—1,204893926
Income (loss) from discontinued operations after income taxes—-9956-194
Net income (loss)—1,105949732
Net income (loss) attributable to noncontrolling interests——22
Net Income (Loss) attributable to Company—1,104947730
[1] Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.———[1]Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
[1]Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
Balance sheet USD ($) shares in Thousands, $ in Millions
4,5213,106
Marketable Securities963
Accounts and notes receivable - net6,3715,676
Inventories5,6675,432
Other current assets767820
Total current assets17,33515,097
Investments in nonconsolidated affiliates160134
Property, Plant and Equipment9,5519,074
Less: Accumulated Depreciation5,3314,975
Net Property, Plant and Equipment4,2204,099
Goodwill10,46510,408
Other intangible assets8,3018,876
Deferred Income Taxes320401
Other Assets2,0441,810
Total Assets42,84540,825
Short-term borrowings and finance lease obligations894750
Accounts Payable4,3984,039
Income Taxes Payable155207
Deferred Revenue3,5793,287
Accrued and other current liabilities3,0992,103
Total current liabilities12,12510,386
Long-term Debt1,6861,953
Deferred Income Tax Liabilities251478
Pension and other post employment benefits - noncurrent2,4342,271
Other noncurrent obligations1,9631,707
Total Noncurrent Liabilities6,3346,409
Common Stock, Shares, Issued672,163685,595
Common stock77
Additional Paid in Capital27,00127,196
Retained earnings (accumulated deficit)-6755
Accumulated other comprehensive income (loss)-2,797-3,469
Total stockholders' equity attributable to the company24,14423,789
Noncontrolling Interests242241
Total Equity24,38624,030
Total Liabilities and Equity42,84540,825
Cash and Cash Equivalents4,5213,106
Marketable Securities963
Accounts and notes receivable - net6,3715,676
Inventories5,6675,432
Other current assets767820
Total current assets17,33515,097
Investments in nonconsolidated affiliates160134
Property, Plant and Equipment9,5519,074
Less: Accumulated Depreciation5,3314,975
Net Property, Plant and Equipment4,2204,099
Goodwill10,46510,408
Other intangible assets8,3018,876
Deferred Income Taxes320401
Other Assets2,0441,810
Total Assets42,84540,825
Short-term borrowings and finance lease obligations894750
Accounts Payable4,3984,039
Income Taxes Payable155207
Deferred Revenue3,5793,287
Accrued and other current liabilities3,2232,096
Total current liabilities12,24910,379
Long-term Debt1,6861,953
Deferred Income Tax Liabilities251478
Pension and other post employment benefits - noncurrent2,4342,271
Other noncurrent obligations1,9631,707
Total Noncurrent Liabilities6,3346,409
Common stock00
Additional Paid in Capital24,61024,464
Retained earnings (accumulated deficit)2,2072,930
Accumulated other comprehensive income (loss)-2,797-3,469
Total stockholders' equity attributable to the company24,25924,035
Noncontrolling Interests32
Total Equity24,26224,037
Total Liabilities and Equity42,84540,825
Due from Parent0-129
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 2024169169
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 20247070
Cash flow statement USD ($) $ in Millions
Dec. 31, 2025Dec. 31, 2024Dec. 31, 2023
Net income (loss)—1,105—919—747
(Income) Loss from Discontinued Operations, after income taxes—99—-56—194
Depreciation and amortization—1,203—1,227—1,211
Provision for (benefit from) deferred income tax—-41—-365—-438
Net periodic pension and OPEB (benefit) cost, net—36—160—138
Pension and OPEB contributions—-136—-151—-149
Net (gain) loss on sales of property, businesses, consolidated companies and investments—-41—-17—-22
Restructuring and Asset Related Charges - net—146—288—336
Other net loss—545—383—578
Accounts and Notes Receivable—-261—-705—358
Inventories—-35—1,110—57
Accounts Payable—231—-115—-663
Deferred Revenue—270—-86—-11
Other Assets and Liabilities—336—-296—-527
Cash Provided by (Used for) Operating Activities - Continuing Operations—3,457—2,296—1,809
Cash Provided by (Used for) Operating Activities - Discontinued Operations—-51—-151—-40
Cash provided by (used for) operating activities—3,406—2,145—1,769
Capital expenditures—-591—-597—-595
Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested—54—5—57
Acquisitions of businesses - Net of Cash Acquired—0—0—-1,456
Investments in and loans to nonconsolidated affiliates—-20—-7—-32
Purchases of investments—0—-144—-148
Proceeds from Sale and Maturities of Investments—135—130—147
Payments for (Proceeds from) Hedge, Investing Activities—-83—63—42
Other investing activities - net—-38—-39—-2
Cash provided by (used for) investing activities—-543—-589—-1,987
Net Change in borrowings (less than 90 days)—0—53—-6
Proceeds from Debt—1,730—3,072—3,429
Payments on Debt—-1,871—-2,885—-2,309
Repurchase of Common Stock—-1,071—-1,009—-756
Proceeds from Exercise of Stock Options—88—60—31
Dividends Paid to stockholders—-475—-458—-439
Other financing activities, net—-45—-32—-49
Cash provided by (used for) financing activities—-1,644—-1,199—-99
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents—84—-93—-143
Increase (decrease) on cash, cash equivalents and restricted cash—1,303—264—-460
Cash, cash equivalents and restricted cash equivalents at beginning of period—3,422[1]3,158[1]3,618
Cash, cash equivalents and restricted cash equivalents at end of period[1]4,725—3,422—3,158
Interest, net of amounts capitalized—191—244—234
Income Taxes—750—707—535
Net income (loss)—1,105—949—732
(Income) Loss from Discontinued Operations, after income taxes—99—-56—194
Depreciation and amortization—1,203—1,227—1,211
Provision for (benefit from) deferred income tax—-41—-365—-438
Net periodic pension and OPEB (benefit) cost, net—36—160—138
Pension and OPEB contributions—-136—-151—-149
Net (gain) loss on sales of property, businesses, consolidated companies and investments—-41—-17—-22
Restructuring and Asset Related Charges - net—146—288—336
Other net loss—545—383—578
Accounts and Notes Receivable—-261—-705—358
Inventories—-35—1,110—57
Accounts Payable—231—-115—-663
Deferred Revenue—270—-86—-11
Other Assets and Liabilities—336—-284—-553
Cash Provided by (Used for) Operating Activities - Continuing Operations—3,457—2,338—1,768
Cash Provided by (Used for) Operating Activities - Discontinued Operations—-51—-151—-40
Cash provided by (used for) operating activities—3,406—2,187—1,728
Capital expenditures—-591—-597—-595
Net payment from (advances to) Parent on in-house banking arrangement—0—361——
Net payment from (advances to) Parent on in-house banking arrangement—————-20
Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested—54—5—57
Acquisitions of businesses - Net of Cash Acquired—0—0—-1,456
Investments in and loans to nonconsolidated affiliates—-20—-7—-32
Purchases of investments—0—-144—-148
Proceeds from Sale and Maturities of Investments—135—130—147
Payments for (Proceeds from) Hedge, Investing Activities—-83—63—42
Other investing activities - net—-38—-39—-2
Cash provided by (used for) investing activities—-543—-228—-2,007
Net Change in borrowings (less than 90 days)—0—53—-6
Net payment from (advances to) Parent on in-house banking arrangement—129————
Net payment from (advances to) Parent on in-house banking arrangement———-129—0
Repayments of Related Party Debt—0—0—-1,129
Proceeds from Debt—1,730—3,072—3,429
Payments on Debt—-1,871—-2,885—-2,309
Proceeds from Exercise of Stock Options—88—60—31
Other financing activities, net—-38—-23—-54
Cash provided by (used for) financing activities—-1,644—-1,602—-38
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents—84—-93—-143
Increase (decrease) on cash, cash equivalents and restricted cash—1,303—264—-460
Cash, cash equivalents and restricted cash equivalents at beginning of period—3,422—3,158—3,618
Cash, cash equivalents and restricted cash equivalents at end of period—4,725—3,422—3,158
Interest, net of amounts capitalized[2]191—244—234
Income Taxes—750—707—535
Dividends Paid to stockholders—-1,682—-1,750—0
[1] See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. [2] Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements.—————[1]See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.[2]Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements.
[1]See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.
[2]Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements.
Note: Commitments and Contingent L'12

Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $49 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page F-43 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ").

Note: Commitments and Contingent Liab

NOTE 15 - COMMITMENTS AND CONTINGENT LIABILITIESGuaranteesIndemnificationsIn connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.Obligations for Supplier Finance ProgramsThe company enters into supplier finance programs with various finance providers in which the company agrees to pay these finance providers the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the finance provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At December 31, 2025 and 2024, the outstanding obligations under supplier finance programs was approximately $121 million and $88 million, respectively, and included within accounts payable in the Consolidated Balance Sheets.

Note: Long-Term Debt and Available Cr

Long-Term DebtDecember 31, 2025December 31, 2024(In millions)AmountWeighted Average RateAmountWeighted Average RatePromissory notes and debentures:Maturing in July 2025$— — %$500 1.70 %Maturing in May 2026600 4.50 %600 4.50 %Maturing in July 2030500 2.30 %500 2.30 %Maturing in May 2032500 5.125 %— — %Maturing in May 2033600 4.80 %600 4.80 %Other loans:Foreign currency loans, various rates and maturities182 12.70 %161 12.70 %Medium-term notes, varying maturities through 2041102 3.76 %104 4.

Note: Income Taxes

INCOME TAXES Domestic and foreign components of income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below: Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,(In millions)202520242023Income (loss) from continuing operations before income taxesDomestic$325 $324 $(414)Foreign1,363 951 1,507 Income (loss) from continuing operations before income taxes$1,688 $1,275 $1,093 Current tax expense (benefit)Federal$87 $285 $143 State and local26 45 40 Foreign412 447 407 Total current tax expense (benefit)$525 $777 $590 Deferred tax expense (benefit) Federal$(139)$(300)$(326)State and local(24)(28)(50)Foreign122 (37)(62)Total deferred tax expense (benefit)$(41)$(365)$(438)Provision for (benefit from) income taxes on continuing operations484 412 152 Net income (loss) from continuing operations after taxes$1,204 $863 $941 The table below provides the updated disclosure requirements of ASU 2023-09, which was adopted on a prospective basis for the year ended December 31, 2025. See Note 3 - Recent Accounting Guidance, to the Consolidated Financial Statements, for a description of the relevant disclosure requirements.The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table: Reconciliation to U.S. Statutory RateFor the Year Ended December 31,2025($ In millions)$%U.S. Federal statutory tax rate$354 21.0 %State and local income tax, net of federal (national) income tax effect 15 0.3 %Foreign tax effectsArgentinaStatutory tax rate differential(17)(1.0)%Withholding tax18 1.1 %Exchange gains/losses(31)(1.8)%Changes in valuation allowances73 4.3 %Other(3)(0.2)%BrazilWithholding tax37 2.2 %Changes in valuation allowances 2153 9.1 %Other(4)(0.2)%IndiaStatutory tax rate differential17 1.0 %Agriculture exemption(41)(2.4)%Withholding tax31 1.8 %Other1 0.1 %SwitzerlandStatutory tax rate differential(91)(5.4)%Cantonal income tax, net59 3.5 %Other(1)(0.1)%Other foreign jurisdictions49 2.9 %Effect of cross-border tax laws (net of related foreign tax credits)Global Intangible Low-Taxed Income (GILTI)24 1.4 %Other12 0.7 %Tax creditsU.S. research and development credit(47)(2.8)%Other foreign tax credits(52)(3.1)%Changes in valuation allowances 374 4.

Note: EIDP Income Taxes Rate Reconcil

Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, to the Consolidated Financial Statements, under the heading "Foreign Currency Risk.

Note: Stock-Based Compensation

STOCK-BASED COMPENSATIONPrior to the Corteva Separation, Corteva employees held equity awards, including stock options, share appreciation rights (“SARs”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”), which were denominated in DowDuPont common stock and, in some cases, in Dow Inc. common stock, and which had originally been issued under the DuPont Equity and Incentive Plan ("EIP"), the Dow Chemical Company 2012 Stock Incentive Plan or the Dow Chemical Company 1988 Award and Option Plan. As discussed in Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, on April 1, 2019 the company entered into an Employee Matters Agreement (the "EMA") with DuPont and Dow that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments were to occur. With some exceptions, the EMA provides for the equitable adjustment of existing equity incentive compensation awards denominated in the common stock of DowDuPont to reflect the occurrence of the Distributions.In connection with the Corteva Separation on June 1, 2019, outstanding DowDuPont-denominated stock options, SARs, RSU and PSU awards were converted into Corteva-denominated awards under the “Employer Method,” or into both DuPont-denominated awards and Corteva-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the Corteva Separation transactions. The conversions of equity awards did not have a material impact on the company’s Consolidated Financial Statements.On June 1, 2019 (“Adoption Date”), in connection with the Corteva Separation, the Omnibus Incentive Plan (the "OIP") became effective.

Note: Cybersecurity Risk Management a

CYBERSECURITYRisk Management and Strategy. The company’s risk management programs for cybersecurity are integrated into the company’s enterprise risk management and general compliance programs and processes. Our cybersecurity program utilizes a layered, defense-in-depth strategy to identify and mitigate cybersecurity threats. The company’s information security team is responsible for the day-to-day management of the company’s global information security program, which includes defining policies and procedures to safeguard our information systems and data, conducting vulnerability, threat and third-party information security assessments, information security event management (i.e., responding to ransomware and other cyber-attacks, business continuity and recovery), evaluating external cyber intelligence, supporting industry cybersecurity efforts and working with governmental agencies. The global information security team also develops training for personnel (e.g., employees and contractors) with access to Corteva’s system to support adherence to the company’s policies and procedures, along with increasing awareness of cyber-related risk. The personnel training includes, but is not limited to, mandatory onboarding training, phishing simulations with automated remediation training, table-top incident response exercises, and educational intranet posting and email campaigns.Our Enterprise Risk Management Committee, which includes the company’s Chief Information Officer (“CIO”) and Chief Information Security Officer (“CISO”), independently assesses and monitors the effectiveness of the company’s cybersecurity risk management programs and strategies. The company’s internal audit function also performs independent reviews and validation of the various programs, including policies and procedures as determined by their annual risk assessment. The company leverages the U.S. Department of Commerce’s National Institute of Standards and Technology (“NIST”) Cybersecurity Framework (“Framework”) as the foundation of its global information security program. The NIST Framework provides standards, guidelines, and practices for organizations to better manage and reduce cybersecurity risk and is designed to foster risk and cybersecurity management communications amongst both internal and external organizational stakeholders.

Note: DEI Document

Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2026 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy).

Long notes are shortened. The full text is in the filing.

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.